First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - NEUROCARE LTD

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: NEUROCARE LTD, WYCLIFFE HOUSE, NORTHERN GENERAL HOSPITAL, HERRIES ROAD, SHEFFIELD, SOUTH YORKSHIRE, S5 7AT. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 March 2022. The company was incorporated on 10 July 1989.

The accounts next due date is 31 December 2023. There are no mortgages.

The above was based on public record information as at 24 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 02402212
Date Incorporated: 10 July 1989
Date Latest Accounts: 31 March 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 02402212
Annual Return: 10 July 2015
Registered Office: WYCLIFFE HOUSE, NORTHERN GENERAL HOSPITAL, HERRIES ROAD, SHEFFIELD, SOUTH YORKSHIRE, S5 7AT
SIC Code and Operations: 47710
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

NEUROCARE LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 4 October 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
13445812 NEUROCARE MEDICAL LIMITED Active
04945849 NEUROCARE PHYSIOTHERAPY LIMITED Active
09315078 NEUROCBT LIMITED Dissolved
10236703 NEUROCED LIMITED Liquidation
10353447 NEUROCED SCIENCE LIMITED Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd